Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19341 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Adrian Mosquera Orgueira und 25 weiteren Autor:innen. Beteiligte Einrichtung: Hematology, University Hospital of Santiago de Compostela, IDIS, Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndromes, Leukemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Taiwan Ministry of Science and Technology, Taiwan Ministry of Health and Welfare.
Abstract (Originalsprache)
Chronic myelomonocytic leukaemia (CMML) is a rare haematological disorder characterized by monocytosis and dysplastic changes in myeloid cell lineages. Accurate risk stratification is essential for guiding treatment decisions and assessing prognosis. This study aimed to validate the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes (AIPSS‐MDS) in CMML and to assess its performance compared with traditional scores using data from a Spanish registry ( n = 1343) and a Taiwanese hospital ( n = 75). In the Spanish cohort, the AIPSS‐MDS accurately predicted overall survival (OS) and leukaemia‐free survival (LFS), outperforming the Revised‐IPSS score. Similarly, in the Taiwanese cohort, the AIPSS‐MDS demonstrated accurate predictions for OS and LFS, showing superiority over the IPSS score and performing better than the CPSS and molecular CPSS scores in differentiating patient outcomes. The consistent performance of the AIPSS‐MDS across both cohorts highlights its generalizability. Its adoption as a valuable tool for personalized treatment decision‐making in CMML enables clinicians to identify high‐risk patients who may benefit from different therapeutic interventions. Future studies should explore the integration of genetic information into the AIPSS‐MDS to further refine risk stratification in CMML and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology, University Hospital of Santiago de Compostela, IDIS, Santiago de Compostela, Spain.
- Hospital Central de Asturias, Oviedo, Spain.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
- Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain.
- Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
ORCID-Profile: Adrian Mosquera Orgueira, Yu-Hung Wang, Marina Diaz-Beya, Maria Julia Montoro, Fernando Ramos Ortega, Andres Jerez, Carlos de Miguel Sanchez, Maria Teresa Cedena Romero, Blanca Xicoy Cirici, María Díez Campelo
Förderung
- Taiwan Ministry of Science and Technology
- Taiwan Ministry of Health and Welfare
Zitieren
APA
Mosquera Orgueira, A., Perez Encinas, M. M., Diaz Varela, N., Wang, Y. H., Mora, E., Diaz-Beya, M., Montoro, M. J., Pomares Marin, H., Ramos Ortega, F., Tormo, M., Jerez, A., Nomdedeu, J., de Miguel Sanchez, C., Arenillas, L., Carcel, P., Cedena Romero, M. T., Xicoy Cirici, B., Rivero Arango, E., Del Orbe Barreto, R. A., …, & Valcárcel, D. (2024). Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. British Journal of Haematology. https://doi.org/10.1111/bjh.19341
Vancouver
Mosquera Orgueira A, Perez Encinas MM, Diaz Varela N, Wang YH, Mora E, Diaz-Beya M, et al. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. British Journal of Haematology. 2024. doi:10.1111/bjh.19341
BibTeX
@article{MosqueraOrgueira2024,
author = {Mosquera Orgueira, Adrian and Perez Encinas, Manuel Mateo and Diaz Varela, Nicolas and Wang, Yu-Hung and Mora, Elvira and Diaz-Beya, Marina and Montoro, Maria Julia and Pomares Marin, Helena and Ramos Ortega, Fernando and Tormo, Mar and Jerez, Andres and Nomdedeu, Josep and de Miguel Sanchez, Carlos and Arenillas, Leonor and Carcel, Paula and Cedena Romero, Maria Teresa and Xicoy Cirici, Blanca and Rivero Arango, Eugenia and Del Orbe Barreto, Rafael Andrés and Benlloch, Luis and Lin, Chien-Chin and Tien, Hwei-Fang and Pérez Míguez, Carlos and Crucitti, Davide and Díez Campelo, María and Valcárcel, David},
title = {Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19341}
}
EUVIMED